Condition
Early Pregnancy Bleeding
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.9% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed2
Not Yet Recruiting1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07608133Not ApplicableCompleted
Comparison of Dydrogesterone Alone Versus Dydrogesterone Plus HCG in Threatened Miscarriage
NCT07609602Not ApplicableNot Yet RecruitingPrimary
The Psychological Effects of Miscarriage Prediction Score: A Prospective Study
NCT05186779TerminatedPrimary
Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy
NCT01570413Not ApplicableCompletedPrimary
Pelvic Examination in Pregnancy
Showing all 4 trials